NCT01037543View on ClinicalTrials.gov

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

HM10460A or placebo or Neulasta

Single SC injection of the appropriate dose of drug ranging from 1.1 mcg/kg to 270 mcg/kg.

Trial Locations (1)

Unknown

California City

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01037543 - Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter